https://www.selleckchem.com/pr....oducts/nec-1s-7-cl-o
01), ICD shocks (SMD -1.71, 95% CI -3.0 to -0.42, p.01) and anti-tachycardia pacing (SMD -1.21, 95% CI -1.98 to -0.44, p.01) following RSDN denervation. The pooled incidence of all-cause mortality after RSDN was 10.16% (95% CI 1.08 to 24.12). There were no major vascular complications, one minor vascular complication-small non-flow limiting renal artery dissection (no intervention needed). RSDN appears to be a safe and effective treatment strategy in patients with prior failed antiarrhythmic drugs and catheter ablatio
Like
Comment
Share
